HMB Supplementation for Faster Recovery After Soft Tissue Trauma

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Recovery from soft tissue trauma, including injuries to muscles, tendons, and ligaments, is prolonged and costly, with existing treatments like Botulinum toxin injections leading to muscle weakness and prolonged recovery times, and there is a need for a nutritional supplement to enhance healing and reduce recovery time.

Innovation Solution

Administration of β-hydroxy-β-methylbutyrate (HMB) composition to enhance recovery from soft tissue trauma, including trauma caused by Botulinum toxin injections, by promoting muscle repair and regeneration, and maintaining strength in injected and contralateral muscles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-generated harmful factors

If Botulinum toxin injections are used to treat muscle disorders, then muscle spasticity and hypertonicity are reduced, but muscle strength and contractile material are lost

Engineering Contradiction:
Improvemuscle spasticity and hypertonicityVSAvoidmuscle strength and contractile material
Core Design Contradiction:
Object-generated harmful factorsVSStrength

Solution Approach 1:

The patent applies HMB supplementation to convert the harmful effect of Botulinum toxin (muscle weakness and atrophy) into a beneficial outcome (preserved muscle strength and reduced recovery time). HMB acts as a protective agent that mitigates the catabolic effects of the toxin while maintaining its therapeutic spasticity-reducing benefits

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the biochemical parameters of muscle metabolism by introducing HMB, which alters protein turnover dynamics. This shifts the balance from protein breakdown (catabolism) induced by Botulinum toxin to protein preservation and synthesis, thereby maintaining muscle mass and strength during treatment

Inventive Principle:
Principle #35Parameter changes

2Reliability

If conventional soft tissue trauma treatment is used, then healing occurs, but recovery time is prolonged and costs are high

Engineering Contradiction:
Improvehealing qualityVSAvoidrecovery time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent administers HMB before and during the early stages of soft tissue trauma recovery to preemptively protect muscle tissue from breakdown. This preliminary nutritional intervention prepares the muscle metabolism for stress, preventing excessive catabolism before it occurs and accelerating the overall healing timeline

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

HMB serves as a biochemical intermediary that mediates between the trauma-induced stress and the muscle's recovery processes. It acts as a protective buffer that reduces the severity of muscle breakdown while promoting efficient repair, thereby shortening recovery time without compromising healing quality

Inventive Principle:
Principle #24Intermediary (Mediator)

3Object-generated harmful factors

If Botulinum toxin is injected into target muscle, then neuromuscular junction function is blocked, but neighboring non-injected muscles are also affected with significant weakness

Engineering Contradiction:
Improveneuromuscular junction blocking effectVSAvoidneighboring muscle strength
Core Design Contradiction:
Object-generated harmful factorsVSStrength

Solution Approach 1:

The patent applies HMB supplementation as a preliminary protective measure against the spillover effects of Botulinum toxin on neighboring muscles. By establishing HMB's protein-protective effects before and during toxin exposure, it preemptively counteracts the weakness that would otherwise affect non-injected muscles through functional disuse and systemic effects

Inventive Principle:
Principle #9Preliminary anti-action

Data Source

PatentUS20250367146A1Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
Publication Date: 2025.12.04 METABOLIC TECHNOLOGIES LLC
  • US20250367146A1 patent drawing
  • US20250367146A1 patent drawing
  • US20250367146A1 patent drawing

AI summary

The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time and enhanced soft tissue healing. Soft tissue trauma includes administration of a Botulinum toxin, such as Botox. Administration of HMB in association with administration of a Botulinum toxin increases muscle strength and/or function in muscle, including adjacent and/or contralateral muscles and prevents or lessens loss of contractile material.